GRAIL, Inc.
GRALNASDAQHealthcare● Active
$61.52
+$1.54(+2.57%)
Market Cap$2.6B
P/E Ratio—
52W High$118.84
52W Low$29.95
GRAIL, Inc. (GRAL) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GRAL · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
-$2.29
Est. -$2.76 · +17.1%
Revenue
$0.04B
Est. $0.04B · +4.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 3-Quarter EPS Beat Streak
GRAL reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | -$2.69 | — | — | — | $0.04B | — |
| ▲ Q2 FY2026 | May 5, 2026 | -$2.76 | -$2.29 | +17.1% | $0.04B | $0.04B | +4.2% |
| ▲ Q1 FY2026 | Feb 19, 2026 | -$3.33 | -$2.44 | +26.7% | $0.04B | $0.04B | +0.0% |
| ▲ Q4 FY2025 | Nov 12, 2025 | -$3.36 | -$2.46 | +26.8% | $0.04B | $0.03B | +4.6% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -$3.14 | -$3.18 | -1.3% | $0.04B | $0.03B | +4.2% |
| ▲ Q2 FY2025 | May 13, 2025 | -$4.03 | -$3.10 | +23.1% | $0.03B | $0.04B | -9.6% |
| ▲ Q1 FY2025 | Feb 20, 2025 | -$4.41 | -$1.86 | +57.8% | $0.04B | $0.04B | +6.8% |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$6.43 | -$3.94 | +38.7% | $0.03B | $0.03B | -16.7% |
Q3 FY2026
Aug 11, 2026
EPS Actual
—
EPS Est.
-$2.69
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
-$2.29
EPS Est.
-$2.76
EPS Surpr.
+17.1%
Revenue
$0.04B
Q1 FY2026
Feb 19, 2026Beat
EPS Actual
-$2.44
EPS Est.
-$3.33
EPS Surpr.
+26.7%
Revenue
$0.04B
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
-$2.46
EPS Est.
-$3.36
EPS Surpr.
+26.8%
Revenue
$0.04B
Q3 FY2025
Aug 12, 2025Miss
EPS Actual
-$3.18
EPS Est.
-$3.14
EPS Surpr.
-1.3%
Revenue
$0.04B
Q2 FY2025
May 13, 2025Beat
EPS Actual
-$3.10
EPS Est.
-$4.03
EPS Surpr.
+23.1%
Revenue
$0.03B
Q1 FY2025
Feb 20, 2025Beat
EPS Actual
-$1.86
EPS Est.
-$4.41
EPS Surpr.
+57.8%
Revenue
$0.04B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$3.94
EPS Est.
-$6.43
EPS Surpr.
+38.7%
Revenue
$0.03B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-2.34 | $-2.20 | $-2.07 | 1 |
| Q3 FY2028 | $-2.32 | $-2.18 | $-2.05 | 1 |
| Q2 FY2028 | $-2.47 | $-2.32 | $-2.18 | 1 |
| Q1 FY2028 | $-2.59 | $-2.44 | $-2.29 | 1 |
| Q4 FY2027 | $-2.96 | $-2.78 | $-2.61 | 1 |
| Q3 FY2027 | $-2.91 | $-2.74 | $-2.57 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +17.1% | $55.66 | $54.40 | -2.26% |
| ▲ Q1 FY2026 | Feb 19, 2026 | +26.7% | $102.28 | $101.53 | -0.73% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +26.8% | $83.39 | $84.77 | +1.65% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -1.3% | $32.69 | $33.60 | +2.78% |
| ▲ Q2 FY2025 | May 13, 2025 | +23.1% | $35.99 | $42.89 | +19.17% |
| ▲ Q1 FY2025 | Feb 20, 2025 | +57.8% | $52.60 | $47.76 | -9.20% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +38.7% | $15.30 | $15.09 | -1.37% |
| — Q3 FY2024 | Aug 13, 2024 | — | $15.37 | $15.84 | +3.06% |
Q2 FY2026-2.26%
Report Date
May 5, 2026
EPS Beat/Miss
+17.1%
Price Before
$55.66
Price After
$54.40
Q1 FY2026-0.73%
Report Date
Feb 19, 2026
EPS Beat/Miss
+26.7%
Price Before
$102.28
Price After
$101.53
Q4 FY2025+1.65%
Report Date
Nov 12, 2025
EPS Beat/Miss
+26.8%
Price Before
$83.39
Price After
$84.77
Q3 FY2025+2.78%
Report Date
Aug 12, 2025
EPS Beat/Miss
-1.3%
Price Before
$32.69
Price After
$33.60
Q2 FY2025+19.17%
Report Date
May 13, 2025
EPS Beat/Miss
+23.1%
Price Before
$35.99
Price After
$42.89
Q1 FY2025-9.20%
Report Date
Feb 20, 2025
EPS Beat/Miss
+57.8%
Price Before
$52.60
Price After
$47.76
Q4 FY2024-1.37%
Report Date
Nov 12, 2024
EPS Beat/Miss
+38.7%
Price Before
$15.30
Price After
$15.09
Q3 FY2024+3.06%
Report Date
Aug 13, 2024
EPS Beat/Miss
—
Price Before
$15.37
Price After
$15.84
Avg Beat Reaction+1.21%
Avg Miss Reaction+2.78%
Beat Rate6 / 8 quarters
Largest Move+19.17% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GRAL ends December
GRAIL, Inc. (GRAL) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $-2.29 — beating the analyst consensus of $-2.76 by +17.1%. GRAL has beaten EPS estimates for 3 consecutive quarters. The next GRAL earnings date is expected around September 1, 2026.
Each quarter, investors track GRAL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GRAL revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GRAL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GRAL earnings · 5 questionsGRAIL, Inc.'s next earnings report is expected around September 1, 2026. GRAL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GRAL historically reports after market close (AMC).
GRAL earnings datewhen is GRAL earningsGRAL next earnings datewhen does GRAL report earningsGRAL earnings calendar
▸ Source: FMP · GRAIL, Inc. SEC filings · US GAAP · GRAIL, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026